Showing results (71-80 of 88) with videos related to
Sort By:
Pageof 9
The Annals of Pharmacotherapy|June 19, 2008
Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation ForumDavid A Garcia, Daniel M Witt, Elaine Hylek, et al.The American Journal of Cardiology|October 21, 2009
Six-month follow-up of patients with in-hospital thrombocytopenia during heparin-based anticoagulation (from the Complications After Thrombocytopenia Caused by Heparin [CATCH] registry)Renato D Lopes, E Magnus Ohman, Christopher B Granger, et al.Neuro-Oncology Advances|July 22, 2024
Germline susceptibility from broad genomic profiling of pediatric brain cancersElaine R Mardis, Samara L Potter, Kathleen M Schieffer, et al.Scientific Reports|October 25, 2024
Defining the transcriptome of PIK3CA-altered cells in a human capillary malformation using single cell long-read sequencingMichelle A Wedemeyer, Tianli Ding, Elizabeth A R Garfinkle, et al.Journal of Thrombosis and Thrombolysis|June 25, 2005
Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry steering committeeE Magnus Ohman, Christopher B Granger, Lawrence Rice, et al.Thrombosis Research|February 17, 2015
Whole blood gene expression profiles distinguish clinical phenotypes of venous thromboembolismDeborah A Lewis, Sunil Suchindran, Michele G Beckman, et al.HGG Advances|November 5, 2024
Expanding the phenotypic spectrum of CSNK2A1-associated Okur-Chung neurodevelopmental syndromeSwetha Ramadesikan, Iftekhar A Showpnil, Mohammad Marhabaie, et al.Blood Advances|May 17, 2023
American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testingSaskia Middeldorp, Robby Nieuwlaat, Lisa Baumann Kreuziger, et al.Annals of Internal Medicine|January 7, 2015
D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort studyClive Kearon, Frederick A Spencer, Denis O'Keeffe, et al.The New England Journal of Medicine|February 26, 2003
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolismPaul M Ridker, Samuel Z Goldhaber, Ellie Danielson, et al.Pageof 9